BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 2658391)

  • 1. [Successful treatment of severe reflux esophagitis with omeprazole: a therapeutic success?].
    Müller-Lissner S
    Z Gastroenterol; 1989 Feb; 27(2):131-2. PubMed ID: 2658391
    [No Abstract]   [Full Text] [Related]  

  • 2. A "significant" new drug for erosive esophagitis and gastroesophageal reflux disease.
    Oncology (Williston Park); 1989 Nov; 3(11):116. PubMed ID: 2701405
    [No Abstract]   [Full Text] [Related]  

  • 3. Lansoprazole versus omeprazole in the treatment of reflux esophagitis.
    Vcev A; Stimac D; Vceva A; Rubinić M; Ivandić A; Ivanis N; Horvat D; Volarić M; Karner I
    Acta Med Croatica; 1997; 51(3):171-4. PubMed ID: 9248117
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Medical treatment of reflux esophagitis.
    Olbe L; Lundell L
    Hepatogastroenterology; 1992 Aug; 39(4):322-4. PubMed ID: 1427576
    [No Abstract]   [Full Text] [Related]  

  • 5. Selection of patients for successful maintenance treatment of esophagitis with low-dose omeprazole: use of 24-hour gastric pH monitoring.
    Ladas SD; Tassios PS; Raptis SA
    Am J Gastroenterol; 2000 Feb; 95(2):374-80. PubMed ID: 10685738
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Acid inhibitors for asthma patients].
    Füessl HS
    MMW Fortschr Med; 2005 Oct; 147(42):4-5. PubMed ID: 16281772
    [No Abstract]   [Full Text] [Related]  

  • 7. Helicobacter pylori and the efficacy of omeprazole therapy for gastroesophageal reflux disease.
    Schenk BE; Kuipers EJ; Klinkenberg-Knol EC; Eskes SA; Meuwissen SG
    Am J Gastroenterol; 1999 Apr; 94(4):884-7. PubMed ID: 10201451
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of omeprazole and ranitidine in the treatment of reflux esophagitis.
    Blum AL; Riecken EO; Dammann HG; Schiessel R; Lux G; Wienbeck M; Rehner M; Witzel L
    N Engl J Med; 1986 Mar; 314(11):716. PubMed ID: 3513011
    [No Abstract]   [Full Text] [Related]  

  • 9. [Omeprazole. An effective antisecretory agent in ulcerative disease and reflux esophagitis].
    Lauritsen K; Laursen LS; Madsen JR
    Ugeskr Laeger; 1989 Jul; 151(28):1831-3. PubMed ID: 2773093
    [No Abstract]   [Full Text] [Related]  

  • 10. Reflux oesophagitis and its treatment.
    Long RG
    Br J Clin Pract Suppl; 1994; 75():36-9; discussion 40. PubMed ID: 8060800
    [No Abstract]   [Full Text] [Related]  

  • 11. Reflux esophagitis: healed! Now what?
    Romero Y; Egan LJ; Murray JA
    Am J Gastroenterol; 2000 Feb; 95(2):337-8. PubMed ID: 10685730
    [No Abstract]   [Full Text] [Related]  

  • 12. Gastroesophageal reflux disease in intellectually disabled individuals: leads for diagnosis and the effect of omeprazole therapy.
    Bohmer CJ; Niezen-de Boer MC; Klinkenberg-Knol EC; Tuynman HA; Voskuil JH; Devillé WL; Meuwissen SG
    Am J Gastroenterol; 1997 Sep; 92(9):1475-9. PubMed ID: 9317066
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Omeprazole and H2-receptor antagonists in the acute treatment of duodenal ulcer, gastric ulcer and reflux oesophagitis: a meta-analysis.
    Eriksson S; Långström G; Rikner L; Carlsson R; Naesdal J
    Eur J Gastroenterol Hepatol; 1995 May; 7(5):467-75. PubMed ID: 7614110
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Reflux esophagitis: a comparative study of lansoprazole and omeprazole as short-term therapy. Preliminary report].
    Córdova-Villalobos JA; Ramírez-Barba EJ; Ramírez-Covarrubias JC
    Rev Gastroenterol Mex; 1996; 61(4):306-9. PubMed ID: 9072780
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Omeprazole in the therapy of acid-induced diseases].
    Simon B; Dammann HG; Müller P
    Z Gastroenterol; 1987 Aug; 25 Suppl 3():146-51. PubMed ID: 2889299
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Omeprazole and reflux oesophagitis.
    Kerr GD
    Aliment Pharmacol Ther; 1994 Apr; 8(2):263. PubMed ID: 8038359
    [No Abstract]   [Full Text] [Related]  

  • 17. [Omeprazole (20 mg daily) compared to ranitidine (150 mg twice daily) in the treatment of esophagitis caused by reflux. Results of a double-blind randomized multicenter trial in France and Belgium].
    Zeitoun P; Rampal P; Barbier P; Isal JP; Eriksson S; Carlsson R
    Gastroenterol Clin Biol; 1989 May; 13(5):457-62. PubMed ID: 2666237
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low-dose omeprazole for erosive esophagitis.
    Epling J; Taylor H
    J Fam Pract; 1999 Feb; 48(2):93-4. PubMed ID: 10037536
    [No Abstract]   [Full Text] [Related]  

  • 19. [Reflux esophagitis: therapeutic indications].
    Cloarec D; Bruley des Varannes S; Galmiche JP
    Rev Prat; 1988 Feb; 38(4):237-48. PubMed ID: 2895495
    [No Abstract]   [Full Text] [Related]  

  • 20. Omeprazole.
    BMJ; 1991 Oct; 303(6806):850-1. PubMed ID: 1932982
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.